Man Group plc Takes Position in HCA Healthcare, Inc. $HCA

Key Points

• Man Group plc bought 60,069 HCA Healthcare shares during the second quarter, worth approximately $23.4 million. Institutional investors collectively own 62.73% of the company.
• Analysts remain broadly positive, with a consensus rating of “Moderate Buy” and an average price target of $462.64, although several firms recently lowered their targets.
• HCA exceeded quarterly expectations, reporting $7.59 in EPS and $20.23 billion in revenue, while revenue grew 8.7% year over year. The company also declared a quarterly dividend of $0.78 per share, equal to a 0.7% annualized yield.

Man Group plc bought a new position in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 60,069 shares of the company's stock, valued at approximately $23,420,000.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Sumitomo Life Insurance Co. increased its position in HCA Healthcare by 1.0% during the fourth quarter. Sumitomo Life Insurance Co. now owns 2,026 shares of the company's stock worth $946,000 after purchasing an additional 20 shares during the last quarter. MJP Associates Inc. ADV increased its holdings in shares of HCA Healthcare by 2.9% during the 4th quarter. MJP Associates Inc. ADV now owns 749 shares of the company's stock worth $350,000 after buying an additional 21 shares during the last quarter. Cary Street Partners Investment Advisory LLC boosted its holdings in HCA Healthcare by 7.5% in the fourth quarter. Cary Street Partners Investment Advisory LLC now owns 300 shares of the company's stock valued at $140,000 after acquiring an additional 21 shares during the last quarter. Anchyra Partners LLC raised its holdings in shares of HCA Healthcare by 3.7% in the 1st quarter. Anchyra Partners LLC now owns 587 shares of the company's stock worth $278,000 after purchasing an additional 21 shares during the period. Finally, Plato Investment Management Ltd grew its holdings in shares of HCA Healthcare by 0.6% during the 4th quarter. Plato Investment Management Ltd now owns 3,908 shares of the company's stock worth $1,833,000 after purchasing an additional 22 shares during the period. Hedge funds and other institutional investors own 62.73% of the company's stock.

Analysts Set New Price Targets

Several research analysts recently commented on HCA shares. Barclays cut their price target on shares of HCA Healthcare from $402.00 to $387.00 and set an "equal weight" rating on the stock in a report on Monday, July 27th. KeyCorp reduced their target price on shares of HCA Healthcare from $475.00 to $435.00 and set an "overweight" rating on the stock in a report on Monday, July 27th. Cantor Fitzgerald lowered their price target on HCA Healthcare from $588.00 to $525.00 and set an "overweight" rating for the company in a report on Tuesday, July 7th. JPMorgan Chase & Co. reduced their price objective on HCA Healthcare from $490.00 to $425.00 and set a "neutral" rating on the stock in a research note on Thursday, August 20th. Finally, Wells Fargo & Company raised their target price on HCA Healthcare from $369.00 to $381.00 and gave the company an "equal weight" rating in a report on Monday, August 3rd. Fourteen equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $462.64.

HCA Healthcare Price Performance

Shares of HCA stock opened at $426.36 on Thursday. The company's fifty day moving average price is $399.36 and its two-hundred day moving average price is $442.21. The firm has a market capitalization of $92.31 billion, a P/E ratio of 14.27, a P/E/G ratio of 1.49 and a beta of 1.10. HCA Healthcare, Inc. has a 12 month low of $353.99 and a 12 month high of $556.52.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its earnings results on Friday, July 24th. The company reported $7.59 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $7.56 by $0.03. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The business had revenue of $20.23 billion for the quarter, compared to analyst estimates of $19.76 billion. During the same period in the previous year, the company earned $6.84 earnings per share. The company's revenue for the quarter was up 8.7% compared to the same quarter last year. On average, sell-side analysts anticipate that HCA Healthcare, Inc. will post 29.42 EPS for the current year.

HCA Healthcare Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Wednesday, September 16th will be paid a $0.78 dividend. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date is Wednesday, September 16th. HCA Healthcare's payout ratio is 10.45%.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source